Skip to main content

Table 3 Baseline information and the decrease of log10 virus load between Day 0 and Day 2

From: Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

Patients

Characteristics

O+P group

O group

P value

All patients

n = 39

n = 43

 

Patients with both day 0 and day 2 available specimens

n = 31

n = 29

 
 

Age (years): mean (SD)

55.45(14.80)

60.79(14.62)

0.94

 

No. of male (%)

22(56.41)

22(51.16)

0.45

 

Time from symptom onset to NAIs administration (days):median(IQR)

7.00(5.00, 8.00)

5.00(4.00, 7.00)

0.46

 

APACHE II score: mean(SD)

18.53(8.83)

22.69(8.53)

0.83

 

Viral load decrease between day 2 and day 0 (log10 /ul): median(IQR)

0.69(0.31, 1.56)

0.00(−0.59, 1.18)

0.06

  1. O oseltamivir monotherapy, O+P oseltamivir-peramivir combination therapy, IQR interquartile range, percentile 25 – percentile75